Literature DB >> 27628737

Searching for the most effective thyrotropin (TSH) threshold to rule-out autonomously functioning thyroid nodules in iodine deficient regions.

Luca Giovanella1,2, Federica D'Aurizio3, Alfredo Campenni'4, Rosaria Maddalena Ruggeri5, Sergio Baldari4, Frederik Anton Verburg6,7, Pierpaolo Trimboli8, Luca Ceriani8.   

Abstract

The purpose of this study is to evaluate the distribution of thyrotropin (TSH) values in patients with autonomously functioning thyroid nodules and to set a TSH threshold above which thyroid scintigraphy would be obviated. Four hundred fifty one patients were included in the present study. Inclusion criteria were age > 18 years, TSH levels between 0.40 and 4.0 mIU/L, detection of a single solid or predominantly solid thyroid nodule >10 mm in the longest diameter. Thyroid ultrasound and thyroid scintigraphy with 99mTc-pertechnetate were performed concurrently in all patients. Among 451 enrolled patients, 173 (38 %) had an autonomously functioning thyroid nodules, of which 137 (79 %) with a normal TSH level. Demographic data and nodules' volume were not significantly different in patients with autonomously functioning thyroid nodules and non-functioning nodules, respectively. However, TSH levels were nonetheless significantly lower in patients with autonomously functioning thyroid nodules compared to those with non-functioning nodules (p < 0.001). Adopting a TSH cutoff level at 2.38 mUI/L, all autonomously functioning thyroid nodules were correctly identified (i.e., 100 % sensitivity) with a 100 % negative predictive value. Our study showed a very high prevalence of autonomously functioning thyroid nodules in mildly iodine-deficient regions and confirmed that serum TSH is not an effective screening test to diagnose an autonomously functioning thyroid nodules. Our data add arguments in favor of the first-line use of thyroid scintigraphy to assess thyroid nodules, at least in iodine deficient areas. As all scintigraphically detected autonomously functioning thyroid nodules had a TSH level below 2.38 mUI/L, a thyroid scintigraphy should be omitted when higher TSH values are found in patients carrying a thyroid nodule.

Entities:  

Keywords:  Fine-needle aspiration; Scintigraphy; Thyroid nodule; Thyrotropin

Mesh:

Substances:

Year:  2016        PMID: 27628737     DOI: 10.1007/s12020-016-1094-3

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  24 in total

1.  Thyroid and obesity: an intriguing relationship.

Authors:  Bernadette Biondi
Journal:  J Clin Endocrinol Metab       Date:  2010-08       Impact factor: 5.958

2.  Biochemical and imaging biomarkers: the search for the Holy Grail.

Authors:  Mario Plebani
Journal:  Clin Chem Lab Med       Date:  2010-08       Impact factor: 3.694

3.  Thyroid guidelines - are thyroid-stimulating hormone assays fit for purpose?

Authors:  Geoff Beckett; Finlay MacKenzie
Journal:  Ann Clin Biochem       Date:  2007-05       Impact factor: 2.057

4.  Goiter prevalence and urinary iodide excretion in a formerly iodine-deficient region after introduction of statutory lodization of common salt.

Authors:  Martin Heinisch; Gerhild Kumnig; Doris Asböck; Peter Mikosch; Hans-Júrgen Gallowitsch; Ewald Kresnik; Iris Gomez; Oliver Unterweger; Peter Lind
Journal:  Thyroid       Date:  2002-09       Impact factor: 6.568

Review 5.  Role of isotope scan, including positron emission tomography/computed tomography, in nodular goitre.

Authors:  Luca Giovanella; Luca Ceriani; Giorgio Treglia
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2014-01-30       Impact factor: 4.690

6.  [Scintigraphically "hot" thyroid nodules mainly go hand in hand with a normal TSH].

Authors:  Rainer Görges; T Kandror; S Kuschnerus; M Zimny; R Pink; H Palmedo; A Hach; H Rau; C Tanner; K Zaplatnikov; A Bockisch; L Freudenberg
Journal:  Nuklearmedizin       Date:  2011-07-08       Impact factor: 1.379

7.  Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).

Authors:  Joseph G Hollowell; Norman W Staehling; W Dana Flanders; W Harry Hannon; Elaine W Gunter; Carole A Spencer; Lewis E Braverman
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

8.  [Functional activity of autonomous adenoma in Germany].

Authors:  D Graf; B Helmich-Kapp; S Graf; F Veit; N Lehmann; K Mann
Journal:  Dtsch Med Wochenschr       Date:  2012-10-02       Impact factor: 0.628

9.  Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism.

Authors:  Martin I Surks; Joseph G Hollowell
Journal:  J Clin Endocrinol Metab       Date:  2007-10-02       Impact factor: 5.958

Review 10.  Personalized Medicine Based on Theranostic Radioiodine Molecular Imaging for Differentiated Thyroid Cancer.

Authors:  Byeong-Cheol Ahn
Journal:  Biomed Res Int       Date:  2016-04-28       Impact factor: 3.411

View more
  4 in total

1.  EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy.

Authors:  Luca Giovanella; Anca M Avram; Ioannis Iakovou; Jennifer Kwak; Susan A Lawson; Elizabeth Lulaj; Markus Luster; Arnoldo Piccardo; Matthias Schmidt; Mark Tulchinsky; Frederick A Verburg; Ely Wolin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-07       Impact factor: 9.236

2.  Real-time elastography in autonomously functioning thyroid nodules: relationship with TSH levels, scintigraphy, and ultrasound patterns.

Authors:  Pierpaolo Trimboli; Gaetano Paone; Maria Chiara Zatelli; Luca Ceriani; Luca Giovanella
Journal:  Endocrine       Date:  2017-03-11       Impact factor: 3.633

3.  Relationship between TSHR, BRAF and PIK3CA gene copy number variations and thyroid nodules.

Authors:  Xiaoli Shi; Mengying Qu; Xing Jin; Lixiang Liu; Fangang Meng; Hongmei Shen
Journal:  Endocrine       Date:  2021-01-11       Impact factor: 3.633

Review 4.  Personalized management of differentiated thyroid cancer in real life - practical guidance from a multidisciplinary panel of experts.

Authors:  Alfredo Campennì; Daniele Barbaro; Marco Guzzo; Francesca Capoccetti; Luca Giovanella
Journal:  Endocrine       Date:  2020-08-09       Impact factor: 3.633

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.